Abstract
THE concept of tumour surveillance implies that specific and nonspecific components of the immune system eliminate tumours in the early phase of malignancy1,2. The immunological mechanisms that control growth of preneoplastic cells are, however, not known. T cells expressing γδ T-cell receptors (TCR) were first described as lymphocytes with reactivity against various tumour cells, which suggests that γδ T cells could mediate tumour surveillance3–6. Here we show that TCRVγ1.1Jγ4Cγ4 transgenic mice7 are spontaneously resistant to acute T-cell leukaemias but cannot reject non-haematopoietic tumours. TCRVγ1.1Jγ4Cγ4+ hybridomas isolated from these mice react in vitro against almost all haematopoietic tumour cell lines tested. Recognition of tumour cells depends on the γδ TCR but is independent of major histocompati-bility complex (MHC) class I, MHC class II, or TAP-2 peptide transporter expression. Ligand recognition is influenced by the murine Nromp gene, which confers resistance or susceptibility to tuberculosis, lepra and leishmaniasis8,9. These data indicate that TCRVγ1.1+ T cells confer spontaneous immunity against haematopoietic tumours in vivo and link innate resistance to bacterial infections with tissue-specific tumour surveillance by γδ+ T cells.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Klein, G. & Boon, T. Curr. Opin. Immun. 5, 687–692 (1993).
Pardoll, D. M. Curr. Opin. Immun. 5, 719–725 (1993).
Haas, W., Pereira, P. & Tonegawa, S. A. Rev. Immun. 11, 637–686 (1993).
Allison, J. P. & Havran, W. L. A. Rev. Immun. 9, 679–705 (1991).
Raulet D. H. A. Rev. Immun. 7, 175–207 (1989).
Kronenberg, M. Curr. Opin. Immun. 6, 64–71 (1994).
Ferrick, D. A. et al. Cell 57, 483–492 (1989).
Radzioch, D. et al. J. Leuk. Biol. 50, 263–270 (1991).
Vidal, S. M., Malo, D., Vogan, K., Skamene, E. & Gros, P. Cell 73, 469–485 (1993).
Correa, I. et al. Proc. natn. Acad. Sci. U.S.A. 89, 653–657 (1992).
Schild, H. et al. Cell 76, 29–37 (1994).
Kärre, K., Ljunggren, H. G., Piontek, G. & Kiessling, R. Nature 319, 675–678 (1986).
O'Brien, R. L. et al. Cell 57, 667–674 (1989).
Yeung, R. A. & Elliot, T. J. Cell 59, 5–8 (1989).
Silva, C. L., Lukacs, K. & Lowrie, D. B. Immunology 78, 35–42 (1993).
Born, W. et al. Science 249, 67–69 (1990).
Munk, M. E., Gatrill, A. J. & Kaufmann, S. H. E. J. Immun. 145, 2434–2439 (1990).
Mombaerts, P., Arnoldi, J., Russ, F., Tonegawa, S. & Kaufmann, S. H. E. Nature 365, 53–56 (1993).
Kabelitz, D. et al. J. exp. Med. 173, 1331–1338 (1991).
De Libero, G. et al. J. exp. Med. 173, 1311–1322 (1991).
Uyemura, K. et al. J. exp. Med. 174, 683–692 (1992).
Barton, C. H., White, J. K., Roach, T. I. A. & Blackwell, J. M. J. exp. Med. 179, 1683–1687 (1994).
Nathan, C. FASEB J. 6, 3051–3061 (1992).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Penninger, J., Wen, T., Timms, E. et al. Spontaneous resistance to acute T-cell leukaemias in TCRVγ1.1Jγ4Cγ4 transgenic mice. Nature 375, 241–244 (1995). https://doi.org/10.1038/375241a0
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/375241a0
This article is cited by
-
Selective, efficient modulation of activated CD4+ αβT cells by the novel humanized antibody GZ-αβTCR targeting human αβTCR
Bone Marrow Transplantation (2015)
-
Gene transfer of pro-IL-18 and IL-1β converting enzyme cDNA induces potent antitumor effects in L1210 cells
Leukemia (2004)
-
The enigmatic specificity of γδ T cells
Immunologic Research (1995)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.
